FDA Accepts Resubmitted Tabelecleucel Application for Review
Atara Biotherapeutics reports that the FDA accepted the resubmitted biologics license application for tabelecleucel (Tab-cel).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.